Proposed mechanisms for the induction of insulin resistance by oxidative stress

被引:311
作者
Bloch-Damti, A [1 ]
Bashan, N [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Soroka Med Ctr, IL-84105 Beer Sheva, Israel
关键词
D O I
10.1089/ars.2005.7.1553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In diabetes (type I and type 2), increased flux of free fatty acids and glucose is associated with increased mitochondrial reactive oxygen species (ROS) production and, as a consequence, increased oxidative stress. ROS have been shown to activate various cellular stress-sensitive pathways, which can interfere with cellular signaling pathways. Exposure of different cell lines to micromolar concentrations of hydrogen peroxide leads to the activation of stress kinases such as c-Jun N-terminal kinase, p38, I kappa B kinase, and extracellular receptor kinase 1/2. This activation is accompanied by a down-regulation of the cellular response to insulin, leading to a reduced ability of insulin to promote glucose uptake, and glycogen and protein synthesis. The mechanisms leading to this down-regulation in oxidized cells are complicated, involving increased serine/threonine phosphorylation of insulin receptor substrate-1 (IRS1), impaired insulin-stimulated redistribution of IRS1 and phosphatidylinositol-kinase between cytosol and low-density microsomal fraction, followed by a reduced protein kinase-B phosphorylation and GLUT4 translocation to the plasma membrane. In addition, prolonged exposure to ROS affects transcription of glucose transporters: whereas the level of GLUT1 is increased, GLUT4 level is reduced. As can be expected, administration of antioxidants such as lipoic acid in oxidized cells, in animal models of diabetes, and in type 2 diabetes shows improved insulin sensitivity. Thus, oxidative stress is presently accepted as a likely causative factor in the development of insulin resistance.
引用
收藏
页码:1553 / 1567
页数:15
相关论文
共 166 条
[31]   Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in L6 myocytes and Fao hepatoma cells [J].
Egawa, K ;
Maegawa, H ;
Shimizu, S ;
Morino, K ;
Nishio, Y ;
Bryer-Ash, M ;
Cheung, AT ;
Kolls, JK ;
Kikkawa, R ;
Kashiwagi, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10207-10211
[32]   Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes [J].
Egawa, K ;
Nakashima, N ;
Sharma, PM ;
Maegawa, H ;
Nagai, Y ;
Kashiwagi, A ;
Kikkawa, R ;
Olefsky, JM .
ENDOCRINOLOGY, 2000, 141 (06) :1930-1935
[33]   Perspective: The search for genes for type 2 diabetes in the post-genome era [J].
Elbein, SC .
ENDOCRINOLOGY, 2002, 143 (06) :2012-2018
[34]   Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action [J].
EldarFinkelman, H ;
Krebs, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9660-9664
[35]   DIABETES AND EMBRYONIC MALFORMATIONS - ROLE OF SUBSTRATE-INDUCED FREE-OXYGEN RADICAL PRODUCTION FOR DYSMORPHOGENESIS IN CULTURED RAT EMBRYOS [J].
ERIKSSON, UJ ;
BORG, LAH .
DIABETES, 1993, 42 (03) :411-419
[36]   Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid thioctic acid - Participation of elements of the insulin signaling pathway [J].
Estrada, DE ;
Ewart, HS ;
Tsakiridis, T ;
Volchuk, A ;
Ramlal, T ;
Tritschler, H ;
Klip, A .
DIABETES, 1996, 45 (12) :1798-1804
[37]   The metabolic syndrome and antioxidant concentrations - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Mokdad, AH ;
Giles, WH ;
Brown, DW .
DIABETES, 2003, 52 (09) :2346-2352
[38]  
Frei B., 1994, NATURAL ANTIOXIDANTS
[39]   Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase [J].
Fryer, LGD ;
Hajduch, E ;
Rencurel, F ;
Salt, IP ;
Hundal, HS ;
Hardie, DG ;
Carling, D .
DIABETES, 2000, 49 (12) :1978-1985
[40]   PLASMA MALONDIALDEHYDE IN TYPE-1 AND TYPE-2 DIABETIC-PATIENTS [J].
GALLOU, G ;
RUELLAND, A ;
LEGRAS, B ;
MAUGENDRE, D ;
ALLANNIC, H ;
CLOAREC, L .
CLINICA CHIMICA ACTA, 1993, 214 (02) :227-234